GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgalign Holdings Inc (OTCPK:SRGAQ) » Definitions » Cyclically Adjusted PS Ratio

Surgalign Holdings (Surgalign Holdings) Cyclically Adjusted PS Ratio : 0.00 (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Surgalign Holdings Cyclically Adjusted PS Ratio?

As of today (2024-05-05), Surgalign Holdings's current share price is $0.018. Surgalign Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was $102.96. Surgalign Holdings's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for Surgalign Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

SRGAQ' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.59   Max: 1.61
Current: 0.03

During the past years, Surgalign Holdings's highest Cyclically Adjusted PS Ratio was 1.61. The lowest was 0.03. And the median was 0.59.

SRGAQ's Cyclically Adjusted PS Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.125 vs SRGAQ: 0.03

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Surgalign Holdings's adjusted revenue per share data for the three months ended in Mar. 2023 was $1.257. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $102.96 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Surgalign Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Surgalign Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgalign Holdings Cyclically Adjusted PS Ratio Chart

Surgalign Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 1.58 0.63 0.14 0.03

Surgalign Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.03 0.03 0.03 0.03

Competitive Comparison of Surgalign Holdings's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Surgalign Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgalign Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgalign Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Surgalign Holdings's Cyclically Adjusted PS Ratio falls into.



Surgalign Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Surgalign Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.018/102.96
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgalign Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Surgalign Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=1.257/127.3478*127.3478
=1.257

Current CPI (Mar. 2023) = 127.3478.

Surgalign Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 22.553 98.518 29.153
201309 29.134 98.790 37.556
201312 32.184 98.326 41.683
201403 32.277 99.695 41.230
201406 34.697 100.560 43.940
201409 34.010 100.428 43.126
201412 37.361 99.070 48.025
201503 35.214 99.621 45.015
201506 36.554 100.684 46.235
201509 33.874 100.392 42.970
201512 38.976 99.792 49.738
201603 34.717 100.470 44.004
201606 34.838 101.688 43.629
201609 34.214 101.861 42.775
201612 38.227 101.863 47.791
201703 35.866 102.862 44.404
201706 36.702 103.349 45.225
201709 26.611 104.136 32.543
201712 34.358 104.011 42.067
201803 33.202 105.290 40.158
201806 33.437 106.317 40.051
201809 26.131 106.507 31.244
201812 -65.805 105.998 -79.059
201903 31.988 107.251 37.982
201906 26.853 108.070 31.643
201909 11.880 108.329 13.966
201912 13.053 108.420 15.332
202003 11.158 108.902 13.048
202006 8.482 108.767 9.931
202009 11.445 109.815 13.272
202012 9.968 109.897 11.551
202103 7.123 111.754 8.117
202106 6.522 114.631 7.246
202109 4.456 115.734 4.903
202112 4.713 117.630 5.102
202203 3.486 121.301 3.660
202206 3.106 125.017 3.164
202209 2.994 125.227 3.045
202212 2.877 125.222 2.926
202303 1.257 127.348 1.257

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Surgalign Holdings  (OTCPK:SRGAQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Surgalign Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Surgalign Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgalign Holdings (Surgalign Holdings) Business Description

Traded in Other Exchanges
N/A
Address
520 Lake Cook Road, Suite 315, Deerfield, IL, USA, 60015
Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.
Executives
Elizabeth A. Lapuma director 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Jill Kathleen Frizzley director P.O. BOX 1541, ONE BLUE HILL PLAZA, PEARL RIVER NY 10965
Paolo Amoruso officer: Chief Legal Officer C/O HYPERDYNAMICS CORPORATION, 12012 WICKCHESTER LANE, SUITE 475, HOUSTON TX 77079
David Lyle officer: Chief Financial Officer 6290 SEQUENCE DRIVE, SAN DIEGO CA 92121
Marc E. Mackey officer: EVP, Digital Surgery 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Terry M. Rich officer: President, Global Spine 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
William Scott Durall officer: Chief Commercial Officer 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Christopher Thunander officer: Chief Accounting Officer 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Thomas Mceachin director 11621 RESEARCH CIRCLE, ALACHUA FL 32615
Nicholas J Valeriani director C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sheryl L Conley director C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355
Enrico Sangiorgio officer: EVP, International 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Stuart F. Simpson director 520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Pawel Lewicki director 296 WOODWARD BLVD., TULSA OK 74114
Jeffrey C Lightcap director 152 W 57TH STREET 43RD FLOOR, NEW YORK NY 10019